minolira — Class III drug recall D-0120-2020
Terminated recall by EPI Health, LLC, reported 2019-10-02. Failed Dissolution Specifications:
| Recall number | D-0120-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | EPI Health, LLC, Charleston, SC, United States |
| Recall initiated | 2019-08-26 |
| Classified | 2019-10-02 |
| Reported by FDA | 2019-10-02 |
| Terminated | 2021-08-18 |
| Reason classes | specification failure |
| NDC | 71403-0102-05 |
| Lot numbers | T900093 |
| Expiration dates | 2020-11 |
Product
minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.
Reason for recall
Failed Dissolution Specifications:
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0120-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.